myomo inc - MYO

MYO

Close Chg Chg %
0.78 0.03 3.95%

Closed Market

0.81

+0.03 (3.95%)

Volume: 377.69K

Last Updated:

Feb 6, 2026, 3:59 PM EDT

Company Overview: myomo inc - MYO

MYO Key Data

Open

$0.78

Day Range

0.76 - 0.82

52 Week Range

0.71 - 6.39

Market Cap

$31.13M

Shares Outstanding

38.44M

Public Float

35.59M

Beta

1.16

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.29

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

518.23K

 

MYO Performance

1 Week
 
-4.29%
 
1 Month
 
-18.73%
 
3 Months
 
-5.93%
 
1 Year
 
-86.79%
 
5 Years
 
-93.18%
 

MYO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About myomo inc - MYO

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans’ administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.

MYO At a Glance

Myomo, Inc.
45 Blue Sky Drive
Burlington, Massachusetts 01803
Phone 1-617-996-9058 Revenue 32.55M
Industry Medical Distributors Net Income -6,183,729.00
Sector Distribution Services 2024 Sales Growth 69.175%
Fiscal Year-end 12 / 2025 Employees 185
View SEC Filings

MYO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 7.47
Price to Book Ratio 8.958
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -41.698
Enterprise Value to Sales 6.955
Total Debt to Enterprise Value 0.036

MYO Efficiency

Revenue/Employee 175,952.427
Income Per Employee -33,425.562
Receivables Turnover 8.509
Total Asset Turnover 1.146

MYO Liquidity

Current Ratio 3.224
Quick Ratio 2.912
Cash Ratio 2.445

MYO Profitability

Gross Margin 71.227
Operating Margin -19.068
Pretax Margin -17.874
Net Margin -18.997
Return on Assets -21.764
Return on Equity -36.695
Return on Total Capital -18.841
Return on Invested Capital -30.035

MYO Capital Structure

Total Debt to Total Equity 32.80
Total Debt to Total Capital 24.699
Total Debt to Total Assets 19.189
Long-Term Debt to Equity 29.773
Long-Term Debt to Total Capital 22.42
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Myomo Inc - MYO

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
13.86M 15.56M 19.24M 32.55M
Sales Growth
+82.72% +12.26% +23.70% +69.17%
Cost of Goods Sold (COGS) incl D&A
3.54M 5.30M 6.06M 9.37M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
335.96K 542.63K 517.68K 776.97K
Depreciation
335.96K 542.63K 517.68K 776.97K
Amortization of Intangibles
- - - -
-
COGS Growth
+36.29% +49.60% +14.27% +54.58%
Gross Income
10.31M 10.25M 13.18M 23.19M
Gross Income Growth
+106.95% -0.57% +28.57% +75.88%
Gross Profit Margin
+74.42% +65.91% +68.51% +71.23%
2021 2022 2023 2024 5-year trend
SG&A Expense
20.58M 20.93M 21.41M 29.39M
Research & Development
2.56M 2.48M 2.64M 4.77M
Other SG&A
18.02M 18.44M 18.78M 24.62M
SGA Growth
+32.90% +1.68% +2.34% +37.26%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
(10.27M) (10.67M) (8.23M) (6.21M)
Non Operating Income/Expense
(15.34K) 21.12K 239.99K 388.59K
Non-Operating Interest Income
- 88.73K 410.27K 388.59K
Equity in Earnings of Affiliates
- - (66.51K) (169.50K)
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -100.00%
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(10.28M) (10.65M) (7.99M) (5.82M)
Pretax Income Growth
+11.07% -3.58% +24.97% +27.20%
Pretax Margin
-74.21% -68.47% -41.53% -17.87%
Income Tax
88.93K 69.94K 156.00K 365.62K
Income Tax - Current - Domestic
2.55M 3.41M (6.04M) 2.54M
Income Tax - Current - Foreign
88.93K 69.94K 156.00K 365.62K
Income Tax - Deferred - Domestic
(2.55M) (3.41M) 6.04M (2.54M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - (66.51K) (169.50K)
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(10.37M) (10.72M) (8.15M) (6.18M)
Minority Interest Expense
- - - -
-
Net Income
(10.37M) (10.72M) (8.15M) (6.18M)
Net Income Growth
+10.30% -3.36% +24.00% +24.10%
Net Margin Growth
-74.86% -68.92% -42.34% -19.00%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(10.37M) (10.72M) (8.15M) (6.18M)
Preferred Dividends
- - - 639.95K
-
Net Income Available to Common
(11.01M) (10.72M) (8.15M) (6.18M)
EPS (Basic)
-1.8888 -1.5204 -0.2762 -0.1638
EPS (Basic) Growth
+48.59% +19.50% +81.83% +40.70%
Basic Shares Outstanding
5.83M 7.05M 29.50M 37.76M
EPS (Diluted)
-1.8888 -1.5204 -0.2762 -0.1638
EPS (Diluted) Growth
+48.59% +19.50% +81.83% +40.70%
Diluted Shares Outstanding
5.83M 7.05M 29.50M 37.76M
EBITDA
(9.93M) (10.13M) (7.71M) (5.43M)
EBITDA Growth
+4.44% -1.99% +23.85% +29.61%
EBITDA Margin
-71.68% -65.12% -40.09% -16.68%

Snapshot

Average Recommendation BUY Average Target Price 5.00
Number of Ratings 5 Current Quarters Estimate -0.086
FY Report Date 03 / 2026 Current Year's Estimate -0.29
Last Quarter’s Earnings -0.09 Median PE on CY Estimate N/A
Year Ago Earnings -0.366 Next Fiscal Year Estimate -0.185
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 5 4
Mean Estimate -0.09 -0.08 -0.29 -0.19
High Estimates -0.07 -0.07 -0.25 -0.15
Low Estimate -0.12 -0.10 -0.35 -0.27
Coefficient of Variance -26.77 -16.72 -13.79 -31.05

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Myomo Inc - MYO

Date Name Shares Transaction Value
Mar 24, 2025 Micah Mitchell Chief Commercial Officer 140,269 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $5.16 per share 723,788.04
Mar 17, 2025 Thomas F. Kirk Director 255,933 Open market or private purchase of non-derivative security Non-derivative transaction at $5 per share 1,279,665.00
Mar 17, 2025 Micah Mitchell Chief Commercial Officer 188,572 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.22 per share 984,345.84
Mar 14, 2025 David A. Henry Chief Financial Officer 385,481 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 David A. Henry Chief Financial Officer 383,462 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.22 per share 2,001,671.64
Mar 14, 2025 Paul R. Gudonis Chief Executive Officer; Director 1,021,671 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Harry Kovelman Chief Medical Officer 127,973 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Harry Kovelman Chief Medical Officer 97,973 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $5.5 per share 538,851.50
Mar 14, 2025 Harry Kovelman Chief Medical Officer 96,477 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.22 per share 503,609.94

Myomo Inc in the News